osthol has been researched along with Alloxan Diabetes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dan, Y; Guo, J; Li, G; Liang, S; Peng, H; Sheng, X; Wu, B; Xu, Z; Zhang, Y | 1 |
Gao, Y; Gong, Y; Jia, T; Li, G; Li, L; Li, S; Liang, S; Liu, H; Liu, S; Ouyang, S; Shi, L; Wu, B; Xu, H; Yang, R; Yi, Z; Yuan, H; Zhang, C; Zhao, S; Zou, L | 1 |
Huang, WJ; Lee, WH; Li, YN; Liang, YC; Lin, RJ; Lin, SY; Wu, HH | 1 |
Chen, YC; Lee, WH; Liang, YC; Lin, HM; Lin, RJ; Lin, SY | 1 |
4 other study(ies) available for osthol and Alloxan Diabetes
Article | Year |
---|---|
Osthole relieves diabetics cardiac autonomic neuropathy associated with P2X3 receptor in ratstellate ganglia.
Topics: Animals; Blood Pressure; Coumarins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia; Male; Molecular Docking Simulation; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Streptozocin | 2020 |
Osthole alleviated diabetic neuropathic pain mediated by the P2X
Topics: Analgesics; Animals; Coumarins; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; Neuralgia; Pain Threshold; Purinergic P2X Receptor Antagonists; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Up-Regulation | 2018 |
N-hydroxycinnamide derivatives of osthole ameliorate hyperglycemia through activation of AMPK and p38 MAPK.
Topics: AMP-Activated Protein Kinases; Animals; Coumaric Acids; Coumarins; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Hypoglycemic Agents; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Rats; Streptozocin | 2015 |
Osthole enhances glucose uptake through activation of AMP-activated protein kinase in skeletal muscle cells.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Line; Cnidium; Coumarins; Diabetes Mellitus, Experimental; Enzyme Activation; Glucose; Glucose Transporter Type 4; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; Phosphorylation; Taiwan | 2011 |